Charles River Laboratories | CRL - Betriebsergebnis

Aktienkurs
157.11
Täglich Wechseln
3.40 2.21%
Monatlich
-4.34%
Jährlich
-9.64%
Q1 Prognose
150.77




Betriebsergebnis Veränderung Datum
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 763M 9M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cigna USD 2.75B 240M 2025-09
Concord Medical Services Hldg CNY -214.02M 126.95M 2023-06
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Elevance Health USD 581M 1.18B 2025-12
Galapagos EUR 780.56M 822.23M 2025-12
Hologic USD 237M 16M 2025-12
Humana USD -808M 1.21B 2025-12
Illumina USD 256M 6M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Lonza CHF 430M 104M 2024-12
McKesson USD 1.66B 159M 2025-12
Merck EUR 474M 738M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Novartis USD 4.5B 363M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
Quest Diagnostics USD 386M 0 2025-12
Revvity USD 145.83M 47.49M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
UnitedHealth USD 3.26B 1.06B 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 270.52M 78.4M 2025-12
West Pharmaceutical Services USD 162.5M 5.1M 2025-12